Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency.

[1]  T. Kipps,et al.  Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. , 1992, Cancer research.

[2]  T. Kipps,et al.  Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Braun,et al.  Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. , 1991, The Journal of clinical investigation.

[4]  L. Young,et al.  Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man , 1991, The Journal of experimental medicine.

[5]  K. Foon,et al.  Chronic lymphocytic leukemia: new insights into biology and therapy. , 1990, Annals of internal medicine.

[6]  J. McCune,et al.  Long-term human hematopoiesis in the SCID-hu mouse , 1990, The Journal of experimental medicine.

[7]  Jack R. Davis,et al.  Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. , 1990, The American journal of pathology.

[8]  C. Robinson,et al.  Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice , 1990, The Journal of experimental medicine.

[9]  N. Cooper,et al.  Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. , 1990, The Journal of clinical investigation.

[10]  M. Bosma,et al.  Defective V‐to‐J recombination of T cell receptor γ chain genes in scid mice , 1990, European journal of immunology.

[11]  J. Dick,et al.  A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. , 1989, Science.

[12]  J. Locker,et al.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation. , 1989, The American journal of pathology.

[13]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[14]  R. Simmons,et al.  Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. , 1989, Transplantation.

[15]  I. Weissman,et al.  Infection of the SCID-hu mouse by HIV-1. , 1988, Science.

[16]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[17]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[18]  F. Alt,et al.  The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism , 1988, Cell.

[19]  M. Zutter,et al.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.

[20]  J. Sklar,et al.  Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus , 1988 .

[21]  T. Tursz,et al.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma. , 1988, The Journal of general virology.

[22]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[23]  M. Martelli,et al.  Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). , 1988, Nouvelle revue francaise d'hematologie.

[24]  R. Hardy,et al.  Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? , 1988, Annual review of immunology.

[25]  G. Brittinger,et al.  Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases * , 1987, British journal of haematology.

[26]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[27]  L. Herzenberg,et al.  The LY‐1B Cell Lineage , 1986 .

[28]  I. Weiler,et al.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency , 1986, Cell.

[29]  D. Oscier,et al.  Autoimmunity in chronic lymphocytic leukaemia. , 1986, Journal of clinical pathology.

[30]  M. Hattori,et al.  Dideoxy sequencing method using denatured plasmid templates. , 1986, Analytical biochemistry.

[31]  D. Staunton,et al.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells , 1985, Journal of virology.

[32]  M. Cooper,et al.  Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies. , 1985, Journal of immunology.

[33]  R. A. Phillips,et al.  Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). , 1985, Journal of immunology.

[34]  M. Cooper,et al.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. , 1984, Journal of immunology.

[35]  G. Keller,et al.  Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. , 1984, Journal of immunology.

[36]  T. Waldmann,et al.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. , 1983, The New England journal of medicine.

[37]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[38]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[39]  M. Epstein,et al.  Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. , 1982, Clinical and experimental immunology.

[40]  R. Fox,et al.  Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. , 1982, Journal of immunology.

[41]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[42]  E. Reinherz,et al.  A monoclonal antibody blocking human T cell function , 1980, European journal of immunology.

[43]  R. Phelps,et al.  Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. , 1980, The American journal of medicine.

[44]  F. Jensen,et al.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects , 1978, The Journal of experimental medicine.

[45]  K. Rajewsky,et al.  Analysis of the repertoire of anti‐NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response , 1978, European journal of immunology.

[46]  J. Goldstein,et al.  Richter's syndrome. , 1977, Southern medical journal.

[47]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[48]  E. Engvall,et al.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. , 1972, Journal of immunology.

[49]  G. Flandrin,et al.  [Chronic lymphoid leukemia with cristals with non-excreted intracellular monoclonal macroglobulin]. , 1971, Nouvelle revue francaise d'hematologie.

[50]  P. Mollison.  Blood transfusion in clinical medicine , 1967 .

[51]  W. Dameshek.  Special Article: Chronic Lymphocytic Leukemia—an Accumulative Disease of Immunologically Incompetent Lymphocytes , 1967 .

[52]  W. Dameshek,et al.  The auto-immune hemolytic anemia of malignant lymphocytic disease. , 1955, Blood.

[53]  M. Richter.  Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia. , 1928, The American journal of pathology.